These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29674173)

  • 41. Optimal Combinations of Chemotherapy and Radiotherapy in Low-Grade Gliomas: A Mathematical Approach.
    Ayala-Hernández LE; Gallegos A; Schucht P; Murek M; Pérez-Romasanta L; Belmonte-Beitia J; Pérez-García VM
    J Pers Med; 2021 Oct; 11(10):. PubMed ID: 34683177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Applications of Machine Learning (ML) and Mathematical Modeling (MM) in Healthcare with Special Focus on Cancer Prognosis and Anticancer Therapy: Current Status and Challenges.
    Hassan J; Saeed SM; Deka L; Uddin MJ; Das DB
    Pharmaceutics; 2024 Feb; 16(2):. PubMed ID: 38399314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Precision oncology for breast cancer through clinical trials.
    Blucher AS; Mills GB; Tsang YH
    Clin Exp Metastasis; 2022 Feb; 39(1):71-78. PubMed ID: 33950412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patient-specific mathematical neuro-oncology: using a simple proliferation and invasion tumor model to inform clinical practice.
    Jackson PR; Juliano J; Hawkins-Daarud A; Rockne RC; Swanson KR
    Bull Math Biol; 2015 May; 77(5):846-56. PubMed ID: 25795318
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent advances in light ion radiation therapy.
    Brahme A
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):603-16. PubMed ID: 14751534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast cancer, pregnancy, and breastfeeding.
    Helewa M; Lévesque P; Provencher D; Lea RH; Rosolowich V; Shapiro HM;
    J Obstet Gynaecol Can; 2002 Feb; 24(2):164-80; quiz 181-4. PubMed ID: 12196882
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microenvironment-driven intratumoral heterogeneity in head and neck cancers: clinical challenges and opportunities for precision medicine.
    Van den Bossche V; Zaryouh H; Vara-Messler M; Vignau J; Machiels JP; Wouters A; Schmitz S; Corbet C
    Drug Resist Updat; 2022 Jan; 60():100806. PubMed ID: 35121337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Model Calibration of Pharmacokinetic-Pharmacodynamic Lung Tumour Dynamics for Anticancer Therapies.
    Ghita M; Billiet C; Copot D; Verellen D; Ionescu CM
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy.
    Enderling H; Alfonso JCL; Moros E; Caudell JJ; Harrison LB
    Trends Cancer; 2019 Aug; 5(8):467-474. PubMed ID: 31421904
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.
    Pixberg C; Zapatka M; Hlevnjak M; Benedetto S; Suppelna JP; Heil J; Smetanay K; Michel L; Fremd C; Körber V; Rübsam M; Buschhorn L; Heublein S; Schäfgen B; Golatta M; Gomez C; von Au A; Wallwiener M; Wolf S; Dikow N; Schaaf C; Gutjahr E; Allgäuer M; Stenzinger A; Pfütze K; Kirsten R; Hübschmann D; Sinn HP; Jäger D; Trumpp A; Schlenk R; Höfer T; Thewes V; Schneeweiss A; Lichter P
    ESMO Open; 2022 Dec; 7(6):100637. PubMed ID: 36423362
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities.
    Veal GJ; Amankwatia EB; Paludetto MN; Möcklinghoff T; Thomson F; André N; Ciccolini J; Chatelut E
    Ther Drug Monit; 2019 Apr; 41(2):142-159. PubMed ID: 30883508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal Control Theory for Personalized Therapeutic Regimens in Oncology: Background, History, Challenges, and Opportunities.
    Jarrett AM; Faghihi D; Ii DAH; Lima EABF; Virostko J; Biros G; Patt D; Yankeelov TE
    J Clin Med; 2020 May; 9(5):. PubMed ID: 32370195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Novel computational biology modeling system can accurately forecast response to neoadjuvant therapy in early breast cancer.
    Peterson JR; Cole JA; Pfeiffer JR; Norris GH; Zhang Y; Lopez-Ramos D; Pandey T; Biancalana M; Esslinger HR; Antony AK; Takiar V
    Breast Cancer Res; 2023 May; 25(1):54. PubMed ID: 37165441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Computational Cancer Cell Models to Guide Precision Breast Cancer Medicine.
    Cheng L; Majumdar A; Stover D; Wu S; Lu Y; Li L
    Genes (Basel); 2020 Feb; 11(3):. PubMed ID: 32121160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Toward Personalized Computer Simulation of Breast Cancer Treatment: A Multiscale Pharmacokinetic and Pharmacodynamic Model Informed by Multitype Patient Data.
    Lai X; Geier OM; Fleischer T; Garred Ø; Borgen E; Funke SW; Kumar S; Rognes ME; Seierstad T; Børresen-Dale AL; Kristensen VN; Engebraaten O; Köhn-Luque A; Frigessi A
    Cancer Res; 2019 Aug; 79(16):4293-4304. PubMed ID: 31118201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical trials in the era of personalized oncology.
    Maitland ML; Schilsky RL
    CA Cancer J Clin; 2011; 61(6):365-81. PubMed ID: 22034206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.